jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Culture & Sensitivity, Aerobic bacteria Other samples( Vitek 2 Compact)

Bacterial/ Viral
image

Report in 72Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Identifies bacteria & antibiotic susceptibility.

1,7022,431

30% OFF

Culture & Sensitivity Aerobic bacteria Other samples (Vitek 2 Compact)

  • Why is it done?
    • Identifies aerobic bacteria present in clinical specimens (wound cultures, body fluid aspirates, tissue samples, cerebrospinal fluid, joint fluid, or other non-routine sample sources)
    • Determines antimicrobial susceptibility patterns to guide targeted antibiotic therapy
    • Confirms bacterial infection in suspected infection cases
    • Monitors effectiveness of antibiotic treatment in ongoing infections
    • Ordered when patients present with signs of systemic infection, localized wound infections, fever of unknown origin, or surgical site infections
    • Typically performed as part of initial diagnostic workup in hospitalized patients or those with clinical signs of infection
  • Normal Range
    • Normal Result: No growth (negative culture) - indicates absence of aerobic bacterial infection in the specimen
    • Interpretation: Normal flora contamination may be noted as non-pathogenic organisms when appropriate for specimen type
    • Abnormal Result: Positive culture with identified bacterial organism - indicates bacterial infection
    • Sensitivity Results: Reported as Susceptible (S), Intermediate (I), or Resistant (R) for various antimicrobial agents
    • Units: Colony forming units per milliliter (CFU/mL) or semiquantitative results (rare, few, moderate, many)
    • Clinical Significance: Negative culture typically excludes bacterial infection; positive culture with organism identification confirms infection and guides antibiotic selection
  • Interpretation
    • No Growth - Negative Culture
      • Indicates no aerobic bacterial infection in the specimen
      • May represent sterile specimen, viral infection, fungal infection, or anaerobic infection
      • Consider clinical context and possibility of anaerobic or other pathogens if clinical suspicion remains high
    • Positive Culture - Organism Identified
      • Confirms bacterial infection with identification of specific pathogenic organism(s)
      • Multiple organisms may indicate mixed infection or contamination - clinical correlation necessary
      • Organism identification performed using Vitek 2 Compact automated system with biochemical testing
    • Susceptibility Interpretation
      • Susceptible (S): Organism is likely to be inhibited by the antibiotic at standard therapeutic doses - preferred agent for treatment
      • Intermediate (I): Organism may be inhibited by the antibiotic at higher therapeutic doses or tissue concentrations - use with caution or consider alternative
      • Resistant (R): Organism is resistant to the antibiotic and will not respond to therapy - avoid this agent and select alternative
    • Factors Affecting Results
      • Specimen quality and type - improper collection, delayed transport, or contamination affects accuracy
      • Prior antibiotic therapy may reduce organism recovery or alter susceptibility patterns
      • Specimen transport conditions and timing - organisms may die or overgrow with inappropriate handling
      • Presence of disinfectants or preservatives may inhibit organism growth
    • Clinical Significance of Patterns
      • Single organism: Usually represents true infection - organism identification and sensitivities guide therapy
      • Multiple organisms: May indicate mixed infection, contamination, or inadequate specimen collection - clinical correlation essential
      • Pan-resistant organism: Indicates multidrug-resistant pathogen requiring careful antibiotic selection and possible infectious disease consultation
  • Associated Organs
    • Primary Organ Systems Involved
      • Respiratory system - pneumonia, bronchitis, lung abscesses
      • Cardiovascular system - endocarditis, septicemia, bacteremia
      • Central nervous system - meningitis, ventriculitis, brain abscess
      • Genitourinary system - urinary tract infections, prostatitis, pyelonephritis
      • Gastrointestinal tract - peritonitis, appendicitis, cholecystitis
      • Integumentary system - cellulitis, abscess, wound infections
      • Musculoskeletal system - osteomyelitis, arthritis, bone infections
    • Common Organisms Detected
      • Gram-positive: Staphylococcus aureus, Streptococcus species, Enterococcus, Bacillus species
      • Gram-negative: Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter, Enterobacter
      • Other: Corynebacterium, Listeria, Serratia, Proteus
    • Associated Medical Conditions
      • Sepsis and septic shock - systemic response to severe infection
      • Nosocomial infections - healthcare-associated infections
      • Immunocompromised states - increased susceptibility to infection
      • Post-surgical infections - complications following surgical procedures
      • Device-related infections - prosthetics, catheters, implants
      • Antibiotic-resistant infections - multidrug-resistant organisms
    • Potential Complications Associated with Abnormal Results
      • Delayed initiation of appropriate therapy increases mortality risk
      • Inadequate antibiotic coverage - inappropriate antimicrobial selection
      • Chronicity and recurrence - persistent infection from inadequate source control
      • Organ dysfunction - multi-organ failure in severe infections
      • Selection of resistant organisms - from inappropriate antibiotic use
  • Follow-up Tests
    • Recommended Follow-up Based on Results
      • Repeat culture - 48-72 hours after initiation of appropriate therapy to confirm organism clearance
      • Blood culture - if bacteremia suspected despite other site culture
      • Imaging studies - CT/MRI to evaluate for complications or loculated infection
      • Anaerobic culture - if anaerobic infection suspected based on specimen site or clinical presentation
    • Complementary Diagnostic Tests
      • Gram stain - immediate morphological identification pending culture results
      • Complete blood count (CBC) - assess for leukocytosis or systemic response
      • Procalcitonin - marker of bacterial infection severity
      • C-reactive protein (CRP) - inflammatory marker of infection response
      • Blood cultures - if septicemia suspected alongside localized infection
      • Metabolic panel - assess renal function, electrolytes for sepsis complications
    • Monitoring and Clinical Follow-up
      • Daily clinical assessment - vital signs, wound appearance, systemic signs during active infection treatment
      • Repeated laboratory studies - CBC, metabolic panel every 24-48 hours in acute infections
      • Treatment response evaluation - clinical improvement, fever resolution within 48-72 hours
      • Duration of therapy - typically 7-21 days depending on infection type and severity
      • Post-treatment follow-up - clinical examination to assess for recurrence or complications
    • Specialized Tests for Resistant Organisms
      • Extended-spectrum beta-lactamase (ESBL) testing - for resistant gram-negative bacteria
      • Carbapenem resistance testing - for highly resistant gram-negative organisms
      • Methicillin resistance testing - for Staphylococcus aureus (MRSA) determination
      • Vancomycin-resistant Enterococcus (VRE) detection - for highly resistant gram-positive organisms
  • Fasting Required?
    • Fasting Requirement: No
    • Culture and sensitivity testing does not require fasting as it involves collection of clinical specimens (wound drainage, body fluids, tissue) rather than blood samples
    • Specimen Collection Requirements
      • Collect specimen using sterile technique to prevent contamination
      • Use appropriate sterile containers provided by the laboratory
      • Collect adequate quantity - typically 1-2 mL or visible amount of specimen material
      • Do not use swabs with wooden applicators or cotton tips - use sterile swabs specifically for culture
      • Avoid specimens contaminated with disinfectants, antiseptics, or preservatives
    • Transport and Handling
      • Transport to laboratory immediately or within 2 hours of collection
      • Keep specimen at room temperature - do not refrigerate unless specific instruction from laboratory
      • Properly label specimen with patient name, date, time of collection, and specimen type
      • Use appropriate transport media if significant delay anticipated
    • Special Instructions
      • For wound cultures - clean surrounding skin with sterile gauze, then culture purulent drainage or deep tissue
      • For body fluid cultures - use sterile technique during aspiration, place in sterile container
      • For tissue cultures - use sterile scalpel or instruments to obtain tissue sample
      • No medications need to be held for specimen collection
      • Inform laboratory if patient is on antibiotics - may affect culture results interpretation

How our test process works!

customers
customers